Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Susan C Modesitt"'
Autor:
Dmitriy Zamarin, Siqing Fu, Elad Sharon, Travis J Hollmann, Alexia Iasonos, Jason A Konner, Susan C Modesitt, Qin Zhou, Alexandre Buckley De Meritens, Carol Aghajanian, Claire F Friedman, Panagiotis A Konstantinopoulos, Bradley R Corr, Michael A Carducci, Alexandra Snyder Charen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background There are limited treatment options for patients with metastatic or recurrent cervical cancer. Platinum-based chemotherapy plus the anti-vascular endothelial growth factor antibody bevacizumab remains the mainstay of advanced treatment. Pe
Externí odkaz:
https://doaj.org/article/b00b2e23c61f4db3a9c932d35221b118
Autor:
Whitney N. Goldsberry, Barbara S. Norquist, Rodney P. Rocconi, Susan C. Modesitt, Renata R. Urban
Publikováno v:
Gynecologic Oncology Reports, Vol 44, Iss , Pp 101103- (2022)
The Society of Gynecologic Oncology (SGO) Journal Club is an open forum to review pertinent studies relevant to controversial topics in the management of gynecologic cancers. On August 3rd, 2022, SGO hosted a Journal Club focused on the role of maint
Externí odkaz:
https://doaj.org/article/2c0e0e8087fa43d6b340cf1b89e27b7d
Autor:
Katherine M. Croft, Bethany M. Sarosiek, Elisa Trowbridge, C. Page Muthusubramanian, Traci Hedrick, Susan C. Modesitt
Publikováno v:
Gynecologic Oncology Reports, Vol 42, Iss , Pp 101008- (2022)
Background: Post-operative opiate prescribing has traditionally been stratified by procedure type with little regard for patient opiate utilization. We sought to evaluate peri-operative factors associated with patient opiate utilization post-operativ
Externí odkaz:
https://doaj.org/article/4f939ba0179f42a3a1bfff6859579682
Autor:
Susan C. Modesitt, Laura J. Havrilesky, Rebecca A. Previs, J. Alejandro Rauh-Hain, J. Michael Straughn, Jamie N. Bakkum-Gamez, Katherine C. Fuh, David E. Cohn
Publikováno v:
Gynecologic Oncology Reports, Vol 42, Iss , Pp 101024- (2022)
Externí odkaz:
https://doaj.org/article/459dac70597943bf8eb22b4c362a2919
Publikováno v:
Gynecologic Oncology Reports, Vol 39, Iss , Pp 100927- (2022)
The goal of this narrative review is to evaluate the literature regarding exercise training as a therapy to prevent or mitigate deleterious side effects of chemotherapy, specifically peripheral neuropathy and sleep disturbances and to make concrete r
Externí odkaz:
https://doaj.org/article/3c132f5f51aa481f9f28b058df86805e
Autor:
Susan C. Modesitt
Publikováno v:
Gynecologic Oncology Reports, Vol 39, Iss , Pp 100932- (2022)
Externí odkaz:
https://doaj.org/article/27f9a4a7ab144c5287680b0c7ceac955
Publikováno v:
Gynecologic Oncology Reports, Vol 28, Iss , Pp 18-22 (2019)
The objectives of this study were to determine both surgical and subsequent cancer outcomes for high-risk women from the University of Virginia's High-Risk Breast/Ovarian Cancer clinic undergoing ovarian cancer risk-reducing surgery. Retrospective re
Externí odkaz:
https://doaj.org/article/fdb4003521c347009044d2a4f3b029ca
Publikováno v:
Gynecologic Oncology Reports, Vol 34, Iss , Pp 100631- (2020)
Vulvar cancer remains a rare entity and treatment options for advanced disease are limited. This case report highlights the excellent response of two patients with FIGO Stage IV vulvar cancer treated with neoadjuvant paclitaxel/carboplatin/bevacizuma
Externí odkaz:
https://doaj.org/article/2e81a8adbff74101a00728b4721b6faf
Autor:
Anne T. Knisely, Martha E. Stewart, Christine Garcia, Martha H. Thomas, Susan C. Modesitt, Kari L. Ring
Publikováno v:
Gynecologic Oncology Reports, Vol 33, Iss , Pp 100587- (2020)
Recent data suggest that BRCA mutation carriers younger than 40 may not benefit from mammography in addition to MRI. Our objective was to evaluate screening modalities utilized in a high-risk population. Clinicopathologic data were abstracted for pat
Externí odkaz:
https://doaj.org/article/c48f864ce13b4a7b840dd489efa49410
Publikováno v:
Gynecologic Oncology Reports, Vol 32, Iss , Pp - (2020)
Small cell carcinoma of the ovary, hypercalcemic type is a rare, aggressive, and typically fatal ovarian cancer that primarily affects young women less than 40 years of age. It is caused by a pathogenic variant in the SMARCA4 gene, with nearly half o
Externí odkaz:
https://doaj.org/article/a0461a7b66214651a462e9ed7f02c496